Flichy-Fernández AJ, Alegre-Domingo T, González-Lemonnier S, Balaguer-Martínez J, Peñarrocha-Diago MA, Jiménez-Soriano Y, Peñarrocha-Oltra D, Bagan JV. Study of serum ctx in 50 oral surgical patients treated with oral bisphosphonates. Med Oral Patol Oral Cir Bucal. 2012 May 1;17 (3):e367-70.

doi:10.4317/medoral.17583

http://dx.doi.org/doi:10.4317/medoral.17583

1. Greenspan SL, Rosen HN, Parker RA. Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women. J Clin Endocrinol Metab. 2000;85:3537-40.
http://dx.doi.org/10.1210/jc.85.10.3537

2. Chailurkit LO, Jongjaroenprasert W, Rungbunnapun S, Ongphiphadhanakul B, Sae-tung S, Rajatanavin R. Effect of alendronate on bone mineral density and bone turnover in Thai postmenopausal osteoporosis. J Bone Miner Metab. 2003;21:421-7.
http://dx.doi.org/10.1007/s00774-003-0438-2
PMid:14586800

3. Brown JE, McCloskey EV, Dewar JA, Body JJ, Cameron DA, Harnett AN, et al. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease. Calcif Tissue Int. 2007;81:341-51.
http://dx.doi.org/10.1007/s00223-007-9061-x
PMid:17874331

4. Peris P, Alvarez L, Vidal S, Kasper D, Leeming DJ, Monegal A, et al. Biochemical response to bisphosphonate therapy in pagetic patients with skull involvement. Calcif Tissue Int. 2006;79:22-6.
http://dx.doi.org/10.1007/s00223-005-0247-9
PMid:16868670

5. Kunchur R, Need A, Hughes T, Goss A. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg. 2009;67:1167-73.
http://dx.doi.org/10.1016/j.joms.2009.02.004
PMid:19446200

6. Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007;65:2397-410.
http://dx.doi.org/10.1016/j.joms.2007.08.003
PMid:18022461

7. Lehrer S, Montazem A, Ramanathan L, Pessin-Minsley M, Pfail J, Stock RG, et al. Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene. J Oral Maxillofac Surg. 2009;67:159-61.
http://dx.doi.org/10.1016/j.joms.2008.09.015
PMid:19070762

8. Bagán JV, Jiménez Y, Murillo J, Hernández S, Poveda R, Sanchis JM, et al. Jaw osteonecrosis associated with bisphosphonates: mul¬tiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol. 2006;42:327-9.
http://dx.doi.org/10.1016/j.oraloncology.2005.08.001
PMid:16275156